GSK1562590, a Slowly Dissociating Urotensin-Ii Receptor Antagonist, Exhibits Prolonged Pharmacodynamic Activity Ex Vivo

British Journal of Pharmacology - United States
doi 10.1111/j.1476-5381.2010.00889.x
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Effects of Urotensin II and Its Specific Receptor Antagonist Urantide on Rat Vascular Smooth Muscle Cells

Bosnian Journal of Basic Medical Sciences
Medicine
2013English

Urotensin II Evokes Potent Vasoconstriction in Humansin Vivo

British Journal of Pharmacology
Pharmacology
2002English

Honokiol as a Specific Collagen Receptor Glycoprotein VI Antagonist on Human Platelets: Functional Ex Vivo and in Vivo Studies

Scientific Reports
Multidisciplinary
2017English

Novel Potent and Efficacious Nonpeptidic Urotensin II Receptor Agonists

English

In Vivo Pharmacodynamic Activity of the Glycopeptide Dalbavancin

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2007English

Protein Expression of Urotensin II, Urotensin-Related Peptide and Their Receptor in the Lungs of Patients With Lymphangioleiomyomatosis

Peptides
BiochemistryEndocrinologyPhysiologyCellularMolecular Neuroscience
2010English

Scintillation Proximity Assay as a High-Throughput Method to Identify Slowly Dissociating Nonpeptide Ligand Binding to the GnRH Receptor

Journal of Biomolecular Screening
Molecular MedicinePharmacologyBiochemistryAnalytical ChemistryBiotechnologyDrug Discovery
2007English

Ex Vivo Interleukin 1 Receptor Antagonist Production on Lipopolysaccharide Stimulation Is Associated With Rheumatoid Arthritis and With Joint Damage

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2007English

Urotensin II: An Inflammatory Cytokine

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy